- Programme
- Horizon 2020 & sub-programmes
- Duration
- 54 months (January 2020 – June 2024)
- Project funding
- ≈ €10 million
- Project partners
- 14
- Project website
- Visit project website
What the project is about
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, and is characterized by a high mortality of up to 30-40%. The mission of the present project is to design and perform a proof-of-concept clinical trial of personalized immunotherapy in sepsis, and within this clinical trial, to develop a next-generation theranostics platform for the design of future personalized immunotherapy trials in sepsis.
Your EURICE contacts
Explore THE COURT
Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.
Enter THE COURT